Company Analysis

Exicure, Inc. (XCUR)

Nasdaq: XCUR · Pharmaceutical Preparations · Chicago, IL · filing with the SEC since 2017
Grade2.6
◀ Past 1.6● Present 2.1▶ Future 3.6
4 est.

Filings

375 filings since 2017 beside 159 insider forms · Non-accelerated filer and smaller reporting company · read from EDGAR on Nov 13, 2026
Due nextNon-accelerated filer and smaller reporting company
10-Q Quarterly report for the quarter ending Sep 30, 2026Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end. by Nov 14, 2026
10-K Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends. by Mar 31, 2027

A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 84 days after the quarter ended. The proxy statement was last filed Nov 12, 2026.

Filings a yearinsider forms included
7346595764584326
20192020202120222023202420252026

2026 counts to Nov 13, 2026.

Listing warning from its exchange (8-K item 3.01): 8 times in the last 36 months, the newest Sep 16, 2026.Officer or director change (8-K item 5.02): 12 times in the last 36 months, the newest Jun 30, 2026.Auditor change (8-K item 4.01): 1 time in the last 36 months, the newest Apr 14, 2025.Warning not to rely on past financial statements (8-K item 4.02): 1 time in the last 36 months, the newest Dec 1, 2023.SEC letters: 2 in the last 36 months, the newest Jul 18, 2025.A late-filing notice, Form NT 10-Q, filed May 15, 2026.A late-filing notice, Form NT 10-Q, filed May 15, 2025.A late-filing notice, Form NT 10-Q, filed May 15, 2024.A late-filing notice, Form NT 10-K, filed Apr 1, 2024.A late-filing notice, Form NT 10-Q, filed Nov 14, 2023.
Insider forms 159

Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.

FiledFormWhat it is, in plain wordsPeriodAsk
Nov 12, 2026 DEF 14A Proxy statement Dec 2, 2026
Nov 10, 2026 8-K items 1.01, 7.01, 9.01 Major agreement signed; Investor disclosure (Regulation FD) · Current report Nov 4, 2026
Nov 2, 2026 PRE 14A Preliminary proxy statement Dec 2, 2026
Sep 16, 2026 8-K item 3.01 Listing warning from its exchange · Current report
Aug 14, 2026 10-Q Quarterly report Jun 30, 2026
Jul 17, 2026 SCHEDULE 13D/A Activist holder update, amended
Jun 30, 2026 8-K item 5.02 Officer or director change · Current report
Jun 1, 2026 8-K item 7.01 Investor disclosure (Regulation FD) · Current report
May 29, 2026 10-Q Quarterly report Mar 31, 2026
May 15, 2026 NT 10-Q Late quarterly report notice Mar 31, 2026
Apr 10, 2026 8-K item 5.02 Officer or director change · Current report Apr 8, 2026
Apr 2, 2026 8-K items 8.01, 9.01 Other event · Current report
Mar 27, 2026 8-K item 5.02 Officer or director change · Current report Mar 25, 2026
Mar 25, 2026 10-K Annual report Dec 31, 2025
Mar 25, 2026 8-K items 2.02, 9.01 Results released · Current report
Feb 17, 2026 8-K item 5.02 Officer or director change · Current report Feb 11, 2026
Feb 10, 2026 8-K item 5.02 Officer or director change · Current report Feb 6, 2026
Jan 22, 2026 8-K items 8.01, 9.01 Other event · Current report Jan 16, 2026
Jan 21, 2026 SCHEDULE 13D/A Activist holder update, amended
Jan 20, 2026 SCHEDULE 13D/A Activist holder update, amended
Jan 9, 2026 SCHEDULE 13D/A Activist holder update, amended
Dec 10, 2025 SCHEDULE 13G/A Large holder update, amended
Nov 17, 2025 8-K items 8.01, 9.01 Other event · Current report Nov 10, 2025
Nov 10, 2025 8-K item 5.07 Shareholder vote · Current report Nov 6, 2025
Nov 7, 2025 10-Q Quarterly report Sep 30, 2025
Nov 7, 2025 8-K items 2.02, 9.01 Results released · Current report
Sep 23, 2025 DEF 14A Proxy statement
Sep 22, 2025 SCHEDULE 13D/A Activist holder update, amended
Sep 9, 2025 8-K item 5.02 Officer or director change · Current report Sep 8, 2025
Aug 8, 2025 10-Q Quarterly report Jun 30, 2025
Aug 8, 2025 8-K items 2.02, 9.01 Results released · Current report
Aug 4, 2025 8-K item 8.01 Other event · Current report
Jul 22, 2025 EFFECT Registration effective
Jul 22, 2025 424B3 Shelf offering
Jul 18, 2025 CORRESP Reply to the SEC
Jul 17, 2025 UPLOAD SEC comment letter
Jul 11, 2025 S-1 Listing registration
Jun 27, 2025 10-Q Quarterly report Mar 31, 2025
Jun 27, 2025 8-K item 9.01 Financial statements and exhibits · Current report
Jun 10, 2025 8-K item 5.02 Officer or director change · Current report Jun 6, 2025
40 of 375 shown

Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.

SI Assistanton XCUR · research, not advice